Share on Pinterest The FDA has approved an esketamine nasal spray for the treatment of depression cases that do not respond to other therapeutic approaches. Image credit: Koldunov/Getty Images.

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of MDD in those who have not responded to at least two oral antidepressants. Hundreds of ...

The FDA's expanded approval will allow the drug to be more accessible with insurance. Parkside Psychiatric Hospital in Tulsa has an on-site Spravato outpatient clinic that sees over 20 patients ...

Water is known to be a great resource for good health, but sparkling water could also offer unique benefits. A new report, published in BMJ Nutrition, Prevention and Health, suggests that ...

MELBOURNE: American Madison Keys produced an inspired display to dethrone top seed Aryna Sabalenka at the Australian Open and capture her maiden Grand Slam title with a battling 6-3, 2-6, 7-5 ...